It is now established that Bcl11b specifies T cell fate.
In Brief
Transcription of a non-coding locus facilitates chromatin folding and compartmentalization to reposition T-lineage-specific enhancer and promoter elements into a single-loop domain.
INTRODUCTION
The differentiation of T cells is orchestrated in the thymus. Upon exposure to Delta-Notch signaling, early T cell progenitors (ETPs) differentiate into multipotent DN2a cells, which in turn develop into committed DN2b cells. DN2b cells subsequently progress into DN3a cells in which TCRb VDJ rearrangement is initiated. Once a productive TCRb chain has been assembled, DN3b cells expand and differentiate into CD4 + CD8 + double-positive (DP) thymocytes. In the DP compartment, thymocytes die by either neglect or negative selection or persist through positive selection to differentiate into CD4 single-positive (CD4SP) or CD8SP cells (Klein et al., 2014; Naito et al., 2011) .
The developmental progression of T cells is regulated by the combined activities of an ensemble of transcriptional regulators. T-lineage development is initiated by the E-proteins that activate the expression of genes encoding components involved in Notch signaling (Bain and Murre, 1998; Ikawa et al., 2006; Miyazaki et al., 2017) . Once instructed to respond to Notch signaling, T cell progenitors activate the expression of Bcl11b, GATA-3, and TCF1 (Yui and Rothenberg, 2014) . Specifically, Bcl11b expression is initiated at the DN2a cell stage to promote developmental progression to the DN2b cell stage. At the DN2b cell stage, Bcl11b expression is further elevated and, in concert with E2A, activates a T-lineage-specific program of gene expression and suppresses the expression of genes associated with alternative cell fates (Liu et al., 2010; Ikawa et al., 2010; Li et al., 2010a; Longabaugh et al., 2017) . The activation of Bcl11b expression in DN2 cells involves Notch signaling, GATA-3, TCF1, and RUNX1 that bind to an enhancer, named Major Peak, located in the Bcl11b intergenic locus control region (Guo et al., 2008; Weber et al., 2011; García-Ojeda et al., 2013; Li et al., 2013) . Recent elegant studies indicated that full activation of Bcl11b expression in developing T cell progenitors requires a rate-limiting transition from an inactive to an active chromatin state (Kueh et al., 2016) .
Here, we have examined how Bcl11b expression is activated to establish T cell fate and suppress the development of lymphoid malignancies. We found that, in developing T cell progenitors, the Bcl11b locus control region, containing a well-characterized enhancer, repositioned from the lamina to the nuclear interior. The repositioning of the Bcl11b enhancer was orchestrated by a non-coding RNA, named ThymoD (thymocyte differentiation factor). ThymoD transcription promoted demethylation at sites associated with CTCF occupancy across the transcribed region and activated cohesin-dependent looping, plausibly involving loop extrusion, to bring the Bcl11b promoter and enhancer into a single loop domain. These results are consistent with a model in which non-coding transcription dictates enhancer-promoter communication at multiple levels: (1) demethylation of CpG residues across the ThymoD transcribed region to permit CTCF occupancy, (2) recruitment of the cohesin complex to the transcribed region to activate cohesin-dependent looping, (3) loop extrusion to juxtapose with great precision the enhancer and promoter into a single-loop domain, (4) repositioning the enhancer from a heterochromatic to an euchromatic environment, and (5) permitting the deposition of activating epigenetic marks across the loop domain to facilitate phase separation.
RESULTS

The Bcl11b Locus Control Region Repositions in Developing T Cell Progenitors
In previous studies, we demonstrated that in multipotent progenitors, the Bcl11b intergenic region was associated with the transcriptionally repressive compartment . To explore the possibility that the Bcl11b locus repositioned in developing thymocytes, adult hematopoietic progenitors were isolated from the bone marrow and cultured on an OP9-DL1 stromal layer in the presence of IL7 and FLT3L (Schmitt and Zú ñ iga-Pflü cker, 2002). Cells were harvested upon reaching the DN2 cell stage and examined for nuclear architecture using HiC (Table S1 ) (Lieberman-Aiden et al., 2009; Rao et al., 2014) . To identify genomic regions that repositioned in developing T cell progenitors, we segregated the DN2 genome into transcriptionally permissive (A) and transcriptionally repressive (B) compartments using principal component analysis. We found that during the transition from the multipotent progenitor to the committed DN2 cell stage, a wide spectrum of genomic regions switched compartments (data not shown). Conspicuous among the genomic regions that repositioned was an intergenic region containing the Bcl11b enhancer ( Figure 1A ) (Li et al., 2013) . Specifically, we found that the Bcl11b intergenic region repositioned from the transcriptionally repressive compartment B to the transcriptionally permissive compartment A ( Figure 1A) . Notably, the repositioning of the Bcl11b intergenic region was associated with de novo genomic interactions involving the Bcl11b enhancer and promoter regions ( Figure 1B ). To validate these findings, formaldehyde fixed cells were hybridized with fluorescently labeled fosmid probes that span the Bcl11b enhancer. As predicted by the HiC analysis, we found that in a large majority of multipotent progenitor cells, the Bcl11b intergenic region was sequestered at the nuclear envelope, whereas in DN2 cells, it was predominantly localized in the nuclear interior ( Figure 1C ). These data indicate that in developing thymocytes, the Bcl11b intergenic region harboring the enhancer repositions from the lamina to the nuclear interior to direct the Bcl11b enhancer to the Bcl11b promoter.
Non-coding RNA Transcription Initiated within the Bcl11b Intergenic Region Activates Bcl11b Transcription Previous studies have suggested that intergenic transcription is associated with the repositioning of genomic regions from heterochromatic to euchromatic genomic regions (Schmitt et al., 2005) . As a first approach to identify such transcripts in developing T cell progenitors, we employed assay for transposase-accessible chromatin sequencing (ATAC-seq) and analyzed RNA sequencing (RNA-seq) reads to detect nucleosome depletion and non-coding transcripts across the Bcl11b intergenic region (Table S1 ) (Buenrostro et al., 2013; Bossen et al., 2015) . This analysis revealed a cluster of ATAC-sensitive sites centered on a previously identified enhancer known to regulate Bcl11b expression (Li et al., 2013) ( Figure 2A ). Four ATAC-sensitive regions associated with this region were identified as CR1, CR2, CR3, and CR4. CR1 corresponds to the Bcl11b enhancer previously named Major Peak (Li et al., 2013) . The roles of CR2, CR3, and CR4 were unknown. CR1, CR2, CR3, and CR4 were depleted of nucleosomes in DN2 cells, but not in pro-B cells, indicating lineage specificity (Figure S1A) . We next examined this region for developmentally regulated non-coding transcripts whose expression preceded or overlapped with Bcl11b expression (Zhang et al., 2012) . Two distinct non-coding RNAs, previously designated as GM16084, initiated from either CR1 (Major Peak) or CR2 ( Figure S1B ). We will hereafter refer to GM16084 as ThymoD. At the DN1 cell stage, ThymoD transcription was initiated from CR2 immediately prior to the induction of Bcl11b expression ( Figure S1B ; data not shown). In the DN2 and DN3 cell stages, ThymoD transcription was initiated from both CR1 and CR2 ( Figure S1B ). As a first approach to examine potential roles for ThymoD in modulating Bcl11b expression, we inserted a poly(A) site upstream of either CR1 or CR2. As a recipient cell line, we used SCIDadh, representing the DN3 cell stage (Carleton et al., 1999) . Upon electroporation of the repair template and gRNAs targeting non-conserved genomic regions either upstream of CR1 or CR2, clones were isolated, expanded, and examined for proper poly(A) site insertion. Clones that harbored the poly(A) insertion on both alleles, flanking either CR1 or CR2, were expanded and examined for ThymoD and Bcl11b expression using real-time PCR. We found that insertion of a poly(A) site upstream of CR1 did not interfere with either ThymoD or Bcl11b transcription ( Figure S1C and S1D). In contrast, when inserted upstream of CR2, ThymoD, as well as Bcl11b transcript abundance, significantly declined ( Figure S1D ). Thus, the insertion of a poly(A) site upstream of CR2, but not CR1, interfered with ThymoD and Bcl11b expression.
Generation of ThymoD p(A)/p(A) Mice
To examine the role of ThymoD in thymocyte development, we generated mice that carried a poly(A) cassette inserted immediately upstream of CR2 (Figure 2A ). gRNAs targeting this region in conjunction with the repair template and Cas9 mRNA were injected into C57BL/6 zygotes ( Figure S2A ) (Yang et al., 2013) . Mice that carried at least three poly(A) cassettes in tandem in the ThymoD locus were viable and generated offspring at the expected Mendelian ratios (data not shown). To validate for proper insertion, PCR primers were generated that were located (C) The Bcl11b intergenic region repositions during the developmental progression from multipotent progenitors to DN2 cells from the nuclear lamina to the nuclear interior. Images represent 3D-FISH analysis using a fosmid probe corresponding to the Bcl11b locus control region. The nuclear envelope was visualized using antibodies directed against the lamina and is indicated in red. The two left images show localization for the Bcl11b enhancer at the nuclear lamina in multipotent progenitors. Right images indicate location of the Bcl11b enhancer in the nuclear interior of DN2 cells. DAPI staining is shown in blue. Bar graph shows fraction of spatial distances (< 500nm) separating the Bcl11b super-enhancer from the nuclear lamina in multipotent progenitor cells (n = 175) and WT DN2 cells (n = 135). Images were digitally magnified. Original magnification was 3100. White bar represents 1 mm.
adjacent and within the targeting construct ( Figure S2A ). Fragment size of amplified products was as expected ( Figure S2B ). Sequenced PCR products verified proper insertion of the p(A) sites ( Figure S2B ; data not shown). DNA sequencing revealed that the putative regulatory elements CR1, CR2, CR3, and CR4 were not mutated by insertion of the poly(A) cassette (data (B) ThymoD transcription activates with high precision and selectivity Bcl11b expression. ThymoD+/+, ThymoD+/p(A), and ThymoD p(A)/p(A) DN2 cells were examined for chromatin accessibility and nascent transcription using ATAC-seq and GRO-seq. ThymoD region is indicated. pAS insertion is shown by red arrow. Enhancer, also named Major Peak or CR1, refers to a previously identified Bcl11b enhancer (Li et al., 2013) . (C and D) 
Lmo4 not shown). To validate that the insertion of poly(A) sites interfered with ThymoD transcription, RNA was isolated from ThymoD +/+, ThymoD +/p(A), and ThymoD p(A)/p(A) thymi. We found that ThymoD transcript levels were severely reduced in thymi isolated from ThymoD p(A)/p(A) mice beyond the p(A) insertion site ( Figure S2C ; data not shown). To examine how ThymoD transcripts were localized in nuclei derived from DN2 cells, we performed RNA-fluorescence in situ hybridization (RNA-FISH). ThymoD transcripts were localized at low abundance in wild-type DN2 cells (data not shown).
To determine how p(A) insertion affected the transcription of ThymoD and Bcl11b, we performed global run-on sequencing (GRO-seq). We found that Bcl11b transcripts, as well as transcripts associated with nearby genes, including Vrk1 and Setd3, were readily detectable in wild-type DN2 cells ( Figure 2B ). To define the transcriptional start sites associated with ThymoD, RNA polymerase II occupancy was analyzed in DN2 cells. Both CR1 and CR2 were enriched for RNA polymerase II occupancy ( Figure 2C ; lowest panel). Using 3 0 -RACE (rapid amplification of cDNA ends), we confirmed that CR1 and CR2 act as promoter elements (data not shown). ThymoD sense and anti-sense transcripts were readily detected in wild-type DN2 cells, albeit at relatively low abundance ( Figure 2B ). However, ThymoD sense and anti-sense transcript levels were severely decreased in ThymoD p(A)/p(A) DN2 cells, indicating that ThymoD transcription is essential to generate a transcriptionally permissive environment ( Figures 2C and 2D) . Notably, Bcl11b, but not Setd3 and Vrk1, transcript levels were sharply reduced in ThymoD p(A)/p(A) DN2 cells as measured by RNA-seq and GRO-seq (Figure 2B ; lowest panel). We conclude that ThymoD transcription activates Bcl11b expression across vast genomic distances with great precision and specificity.
ThymoD Specifies T Cell Fate
To determine whether ThymoD expression specifies T cell fate, thymi were isolated from ThymoD +/+, ThymoD +/p(A), and ThymoD p(A)/p(A) mice and analyzed for developmental abnormalities. We found that thymocyte cellularity in ThymoD p(A)/ p(A) mice was reduced 2-fold when compared to thymi derived from wild-type mice ( Figure 3A) . The proportion and number of the DN1 and DN2 compartments were increased in thymi isolated from ThymoD p(A)/p(A) mice as compared to wild-type mice, whereas the DN3 and D4 compartments were reduced ( Figures 3B and 3C ). ThymoD p(A)/p(A) thymi also displayed abnormal ratios of DP and SP cells ( Figure S3A ). The gd T cell compartment was reduced in ThymoD p(A)p(A) thymi as compared to wild-type thymi ( Figure S3B ). We also observed increases in the percentages of NK1. (Liu et al., 2010; Ikawa et al., 2010; Li et al., 2010b; Kamimura et al., 2007; Gutierrez et al., 2011) . Indeed, Bcl11b expression in DN2-DN3 cells sorted from ThymoD p(A)/p(A) mice was significantly reduced, as was observed upon insertion of a poly(A) cassette into the ThymoD locus of the SCIDadh cell line ( Figure 3D ). To further validate the notion that ThymoD and Bcl11b expression were linked, DN2 cells were generated in vitro using OP9-DL1 cells. We found that hematopoietic progenitors derived from ThymoD p(A)/p(A) mice failed to develop beyond the DN2 stage upon culture on OP9-DL1 monolayers, consistent with the developmental arrest observed in ThymoD p(A)/p(A) thymi in vivo ( Figure 3E ). Likewise, when cultured on OP9-DL1 cells, ThymoD p(A)p(A) progenitors displayed defects in T ( Figure S4A ). To examine Bcl11b expression levels in cultured DN2 cells derived from ThymoD p(A)/p(A) mice, RNA was extracted and analyzed by real-time PCR. As was observed in progenitors derived from ThymoD p(A)/p(A) mice, Bcl11b levels were significantly decreased in ThymoD Figure S4B ). To determine the extent of overlap between the transcription signatures between ThymoD p(A)/p(A) and Bcl11b-deficient DN2 cells, RNA-seq profiles were compared (Longabaugh et al., 2017) . We found that many of the differentially expressed genes in ThymoD p(A)/p(A) were modulated during the DN2 to DN3 transition, and the vast majority overlapped with those differentially expressed in Bcl11b-deficient DN2 cells ( Figure 3F ). This set of differentially expressed genes was closely linked with specification and commitment of adaptive and innate immune cells (Figures 3G, 3H, and S4C) . Prominent among the regulators that characterize adaptive and innate immune cell development were Id2, CD3ε, Runx2, Sox13, Il2rb, Zbtb7b, Fcgr3, Ikzf3, c-kit, Notch3, and Dntt ( Figure 3H ) (Liu et al., 2010; Ikawa et al., 2010; Li et al., 2010a; Rothenberg et al., 2016) . These data directly link ThymoD and Bcl11b into a common pathway to specify T cell fate. Figure 4A and Table S1 ). In contrast, a mere 30 genomic regions were associated in different compartments upon comparing ThymoD+/+ and ThymoD p(A)/p(A) DN2 cells (Figure 4B and Table S1 ). Conspicuous among these was the Bcl11b intergenic region ( Figure 4B ). The finding that a rather restricted number of genomic regions flipped PC1 values raised the question as how this compares to changes in compartmentalization during the DN2 to DN3 transition. To explore this possibility, we performed HiC on isolated RAG-deficient thymocytes derived from fetal liver cells and cultured on OP9-DL1 cells. Contact maps were generated from DN3 HiC reads and directly compared to those observed for DN2 cells. We found that a total of sixty genomic regions switched compartments during the DN2 to DN3 transition (Tables S2 and S3 ). We next compared changes in the PC1 distribution across chromosomes for wildtype DN2 versus ThymoD p(A)/p(A) DN2, wild-type DN2 versus wild-type DN3, and wild-type DN2 versus multipotent progenitors. The correlation coefficient of interactions for each locus for the paired cell types was calculated and plotted as the mean correlation coefficient for all loci across each chromosome. We found that most of the differences in PC1 values in wild-type versus ThymoD p(A)/p(A) DN2 cells were restricted to chromosome 12, where the Bcl11 locus is located ( Figure S4D ). These data are consistent with the notion that ThymoD acts locally to orchestrate compartmentalization. As expected, the changes in compartmentalization in wild-type DN2 versus ThymoD p(A)/p(A) DN2 cells were also closely associated with differences in long-range genomic interactions that span the Bcl11b locus control region ( Figure 4C ). In wild-type DN2 cells, we observed an elaborate pattern of looping involving the Bcl11b locus control region and the Bcl11b coding region (Figure 4C) . In contrast, ThymoD p(A)/p(A) DN2 cells were severely depleted for such interactions. Rather, we observed genomic interactions spanning vast genomic distances and primarily involving neighboring heterochromatic regions ( Figure 4C ). To validate the changes in compartmentalization, we performed immune-3D-FISH using antibodies directed against the lamina and fluorescently labeled probes corresponding to the Bcl11b intergenic region. As expected, we found that in wild-type DN2 cells, the Bcl11b intergenic region was predominantly localized at the nuclear interior, whereas in ThymoD p(A)/p(A) DN2 cells, the Bcl11b locus was retained for the large majority of cells at or near the nuclear lamina ( Figure 4D ). Collectively, these observations indicate that ThymoD expression is essential to release the Bcl11b intergenic region from the nuclear lamina.
Nascent ThymoD Transcription Acts in Cis to Release the Bcl11b Locus Control Region from the Lamina While the data described above indicate that ThymoD transcription is essential to release the Bcl11b intergenic region from the nuclear lamina, it remained to be determined whether ThymoD transcription acts in cis or in trans. To address this question, ThymoD+/+ and heterozygous ThymoD+/p(A) DN2 cells were examined for attachment of the Bcl11b intergenic region to the nuclear lamina using immune-3D-FISH. We found that in the vast majority of DN2 +/p(A) cells, a single allele of the Bcl11b super-enhancer was sequestered at the nuclear lamina, whereas the other allele was positioned in the nuclear interior ( Figure 4E ). Thus, these data indicate that ThymoD expression acts in cis to modulate the nuclear location of the Bcl11b locus control region. To test whether forced ThymoD or ThymoD2 expression in ThymoD +/p(A) DN2 cells has the ability to release the ThymoD p(A) allele in trans, hematopoietic progenitor cells isolated from ThymoD +/p(A) bone marrow were transduced with virus expressing vector alone, ThymoD (exons 1-3), and ThymoD2 (exons 1, 2, and 4) and were examined for the nuclear positioning of the Bcl11b locus control re- (mm10) indicates that ThymoD and Gm16086 span a single transcription unit. CR1, also named Major Peak, refers to a previously identified Bcl11b enhancer (Li et al., 2013) . ChIP-seq reads were corrected for input reads. gion (data not shown). We found that the ThymoD p(A) allele remained at the nuclear lamina regardless of ectopic ThymoD or ThymoD2 expression (data not shown). Taken together, these findings demonstrate that (1) nascent ThymoD transcription is required to release the Bcl11b locus control region from the nuclear lamina and (2) ThymoD transcripts generated at wild-type alleles do not have the ability to act in trans and release the other Bcl11b allele from the lamina. We conclude that in developing T cell progenitors ThymoD expression acts in cis to release the Bcl11b locus control region from the nuclear lamina.
ThymoD-Induced Structural Changes in Chromatin Topology Foster Bcl11b Enhancer-Promoter Communication
To determine how ThymoD transcription modulates local chromatin folding, we examined HiC contact reads derived from wild-type and ThymoD p(A)/p(A) DN2 for genomic interactions across the Bcl11b intergenic and genic regions ( Figure 5A ). In wild-type DN2 cells, the most significant interactions across a 7 Mb genomic region involved the Bcl11b enhancer and promoter ( Figure 5A ). Strikingly, genomic interactions associated (1-11) (0.9-2) (0.9-2) (0.9-2) (0.9-2) (0.9-2.5) (0.9-2.5) with the enhancer and promoter were greatly diminished in DN2 cells derived from ThymoD p(A)/p(A) mice ( Figure 5A ). Rather, we found that ThymoD p(A)/p(A) DN2 cells were highly enriched for loops involving the Bcl11b genic and promoter regions with heterochromatin ( Figures 4C and 5A ). Thus, ThymoD transcription promotes a pattern of genomic interactions that greatly enriches genomic encounters involving the Bcl11b promoter and enhancer.
To determine how genomic interactions were affected by ThymoD expression, we examined wild-type and ThymoD p(A)/ p(A) DN2 cells for CTCF and cohesin (SMC3) occupancy (Figure 5B) . We found that in wild-type DN2 cells, CTCF and SMC3 bound to multiple sites that spread across the Bcl11b intergenic and genic regions ( Figures 5B and 5C ). As expected, the majority of CTCF bound sites overlapped with SMC3 occupancy (Figure 5A ). Importantly, both CTCF and SMC3 occupancy across the Bcl11b intergenic region were severely affected in ThymoD p(A)/p(A) DN2 cells ( Figure 5B ). CTCF and SMC3 occupancy was also affected at the Bcl11b promoter ( Figures 5C and S5A ).
It could be argued that ThymoD p(A)/p(A) DN2 cells were developmentally distinct from that of wild-type DN2 cells and that the abnormalities observed in CTCF and SMC3 occupancy were caused by a developmental arrest. To address this possibility, we examined CTCF and SMC3 occupancy in ThymoD+/ p(A) mice, in which thymocyte development was not perturbed. We found that in ThymoD +/p(A) DN2 cells, CTCF and SMC3 occupancy was reduced 2-fold across the Bcl11b intergenic region, suggesting a direct link between ThymoD transcription and CTCF and SMC3 occupancy ( Figure 5B) .
As a first approach to determine the mechanism by which ThymoD transcription promotes CTCF and SMC3 occupancy, we examined the ThymoD transcribed region for nucleosome depletion, as well as for the deposition of epigenetic marks (Figures 6A and 6B) . We found that ThymoD transcription affected nucleosome depletion and the deposition of epigenetic marks associated with active transcription and the deposition of H3.3 across the Bcl11b promoter, but not genomic regions that flank the Bcl11b regulatory elements ( Figures 6A, 6B , and S5A).
The absence of CTCF occupancy in ThymoD p(A)/p(A) DN2 cells raised the question as to why CTCF failed to bind its cognate sites across the ThymoD transcribed region. Since recent studies have demonstrated that non-coding transcription is closely associated with CpG hypomethylation, we considered the possibility that transcription across the ThymoD region acts to recruit members of the Tet protein family (Benner et al., 2015) . Hence, we examined DNA isolated from wild-type and ThymoD p(A)/p(A) DN2 cells for cytosine DNA methylation using genomewide bisulfite sequencing ( Figure 6B ; bottom tracks). Notably, several CpG residues associated with CTCF binding sites across the ThymoD transcribed region were hypermethylated in ThymoD p(A)/p(A) DN2 cells ( Figure 6B ; upper and bottom tracks). Taken together, these data indicate that ThymoD transcription is essential to (1) demethylate CpG residues closely associated with CTCF bound sites, (2) recruit members of the cohesin complex to the transcribed region, and (3) reposition the Bcl11b enhancer from a repressive to a transcriptionally permissive neighborhood.
Nascent ThymoD Transcription Is Essential to Recruit
Cohesin to the Bcl11b Locus Control Region The data described above indicate that ThymoD transcription is associated with modulating chromatin topology to bring the Bcl11b enhancer and promoter elements within close spatial proximity. To determine whether nascent ThymoD transcription is required to recruit members of the cohesin complex to the Bcl11b locus control region, wild-type DN2 cells were incubated in the presence of actinomycin D for 15, 30, and 60 min. Treated cells were formaldehyde fixed and immunoprecipitated with antibodies directed against RNA polymerase II and SMC3 followed by genome-wide sequencing. Consistent with previous observations, we found that SMC3 occupancy was significantly depleted at sites associated with RNA polymerase II occupancy ( Figure 6C and Table S1 ) (Izumi et al., 2015; Bhardwaj et al., 2016) . We next evaluated whether in DN2 cells nascent ThymoD transcription directly recruits SMC3. We found that DN2 cells treated with actinomycin D showed a significant reduction of SMC3 occupancy across the transcribed region ( Figures 6D and S5B ). Notably, a brief 15 min incubation with actinomycin D significantly affected SCM3 occupancy ( Figure 6E ). We conclude that the nascent (C) Cohesin occupancy in DN2 cells is closely associated with active transcription start sites. DN2 cells were incubated in the presence of actinomycin D for the indicated time points, formaldehyde fixed, and analyzed for SMC3 occupancy using ChIP-seq. Active transcription start sites were identified using RNA polymerase II ChIP-seq. Plotted is the -log 10 of p values of the Fisher test of the contingency table (Table S1 ). The analysis indicates preferential loss of cohesin occupancy at active TSS sites. (D) SMC3 loading across the ThymoD transcribed region requires nascent transcription. SMC reads were determined across the ThymoD locus (chr12: 108.345À108.405 Mb) in DN2 cells treated in the absence or presence of actinomycin D for indicated times and normalized to the total read number. The mean and standard deviation for each experiment were derived from 20 independent samples using boot strapping for all reads across the genome. (E) Nascent RNA transcription targets SMC3 to the ThymoD locus. DN2 cells were incubated in the absence or presence of actinomycin D for 15 min and analyzed for SMC3 occupancy using ChIP-seq. Representative track shows a reduction of SMC3 occupancy across the ThymoD locus. ThymoD transcription acts in cis to directly promote SMC3 loading across the transcribed region.
Compartmentalization and Cohesin-Dependent Looping Is Reversible in ThymoD-Deficient Lymphomas and Leukemias As described above, ThymoD p(A)/p(A) mice readily develop lymphoma or leukemia. To determine whether the Bcl11b intergenic remained attached to the nuclear lamina in ThymoD p(A)/ p(A) lymphomas, long-term cultures were established from the tumors. Tumors isolated from aged ThymoD p(A)/p(A) mice displayed a higher fraction of blasting cells that frequently adopted irregular nuclear morphologies and readily expanded in tissue culture ( Figure 7A ). Long-term cultures were established either in the absence or presence of OP9-DL1 stromal cells. From these expanding cultures, we established independent cell lines representing either lymphomas or leukemias. To determine whether the expression of ThymoD and Bcl11b remained silent in the lymphomas and leukemias, the tumors were examined for ThymoD and Bcl11b expression using RNA-seq ( Figure S6 ). As expected, ThymoD transcription was blocked at the poly(A) insertion in all of the tumors ( Figure S6 ). Intriguingly, three of the tumors expressed anti-sense transcription at relatively high levels in three of the six tumors ( Figure S6 ). Notably, lymphomas and leukemias that expressed high levels of anti-sense transcription also abundantly expressed Bcl11b ( Figure S6 ). These data indicate that a subset of lymphoid malignancies that develop in ThymoD p(A)/p(A) mice display coordinate ThymoD anti-sense and Bcl11b transcription, whereas in tumors that failed to induce anti-sense ThymoD transcription, Bcl11b expression remained suppressed.
To examine whether the activation of ThymoD and Bcl11b expression in a subset of lymphoma cell lines was associated with chromatin accessibility and SMC3 occupancy across the ThymoD region, three lymphomas (3, 5, and 6) were examined using ATAC-seq and SMC3 ChIP-seq ( Figure 7B ). As predicted by the analyses described above, lymphomas that were associated with coordinate ThymoD and Bcl11b expression showed widespread ATAC reads across the ThymoD locus and were enriched for SMC3 occupancy ( Figure 7B ).
To determine whether the induction of ThymoD and Bcl11b expression, as well as the selective increase in SCM3 occupancy, was associated with changes in nuclear location, tumors 3 and 5 were examined by 3D-FISH for compartmentalization. We found that the majority of cells derived from tumor 3, which coordinately expressed high levels of ThymoD and Bcl11b, exhibited localization of the Bcl11b intergenic region that was localized away from the nuclear lamina ( Figure 7C ). In contrast, the localization of ThymoD in tumor 5, which expresses low levels of ThymoD and Bcl11b, was near or on the nuclear lamina ( Figure 7C ). These data indicate that the insertion of a poly(A) cassette in the ThymoD locus does not irreversibly attach the ThymoD locus to the nuclear lamina. Instead, ThymoD transcription, either sense or anti-sense, promotes SMC3 occupancy and cohesin-dependent looping, changes in compartmentalization, and the activation of Bcl11b expression to specify T cell fate ( Figure S7 ).
DISCUSSION
Specifying Immune Cell Fate by Non-coding Transcription While it is now well established that genomic regions reposition during developmental progression, it is not understood how such changes in nuclear location are regulated. Here, we provide insight into the mechanism that underpins the repositioning of regulatory elements. We identify a non-coding RNA, named ThymoD, which acts to reposition the Bcl11 enhancer away from the lamina to the nuclear interior and sequester the Bcl11b promoter and enhancer region into a single-loop domain. How does ThymoD accomplish the repositioning of the Bcl11b enhancer? The phenotype revealed in ThymoD+/p(A) thymocytes strongly suggests that ThymoD acts in cis on nearby gene expression, consistent with previous observations that nascent transcription, rather than biochemical activities, associated with a subset of non-coding RNAs executes their function (Melé and Rinn, 2016; Engreitz et al., 2016) . Here, we found that the vast majority of DN2+/p(A) cells display one Bcl11b allele located at the nuclear lamina and one in the nuclear interior. Thus, ThymoD acts in cis to release the Bcl11b enhancer from the lamina and to active Bcl11b gene expression. How does ThymoD perform this task? We propose a stepwise mechanism. The induction of Bcl11b expression is initiated and maintained in early T cell progenitors by activating a yet-to-be-identified enhancer associated with the ThymoD locus. Next, we suggest that the ThymoD transcribed region directs dioxygenases, Tet proteins, to specific residues that are associated with CTCF occupancy. This explains why, in the absence of ThymoD expression, CTCF occupancy is perturbed across the transcribed region, consistent with previous observations indicating that nascent transcription is closely associated with hypomethylated DNA (Benner et al., 2015) . Previous observations have also indicated that mice deficient for Tet2 and Tet3 expression displayed defects in NKT cell development and lymphoproliferative disease and also exhibited significantly lower abundance of Bcl11b expression (Tsagaratou et al., 2017) . Although still to be proven, it is conceivable that the absence of Tet2 and Tet3 expression in NKT cells leads to hypermethylated CpG residues across the ThymoD transcribed region and in a failure to efficiently activate Bcl11b expression, plausibly resulting in lympho-proliferative disease and defects in NKT cell development. How the Tet proteins target specific CpG residues spanning the transcribed region is an important question that needs to be addressed but may involve distinct secondary DNA structures that are induced either by sense or anti-sense transcription.
Regardless of the precise mechanism, these data link non-coding transcription and Tet targeting into a common pathway.
ThymoD transcription was associated with cohesin occupancy consistent with previous studies (Izumi et al., 2015; Bhardwaj et al., 2016; Busslinger et al., 2017) . Recruitment of the cohesin complex, in turn, activates an elaborate and coherent pattern of looping, likely involving loop extrusion, to bring the enhancer and promoter region in a singular loop domain (Nasmyth, 2001; Sanborn et al., 2015; Fudenberg et al., 2016) . Juxtaposing paired enhancer and promoter regions, separated by vast genomic distances, would yield greatly reduced first-passage times (Lucas et al., 2014) . We note that loop extrusion would permit the repositioning of paired enhancers and promoters with great precision even when separated by vast genomic distances. Finally, loop extrusion would sequester the loop domain away from the transcriptionally repressive environment to the euchromatic compartment. We suggest that, once localized in the transcriptionally permissive compartment, transcriptional regulators associated with T-lineage commitment, including GATA-3, TCF1, and RUNX1, would bind enhancer elements across the loop domain to orchestrate the deposition of activating histone marks, as well as the histone variant H3.3, facilitating enhancer-promoter communication that may involve phase separation (Hnisz et al., 2017) . Such a sequential order of gene activation is consistent with the notion that ThymoD transcription (DN1 stage) precedes the expression of non-coding RNAs initiated from the enhancer regions (DN2a stage). In sum, we propose a model in which nascent ThymoD transcription dictates enhancer-promoter communication at multiple steps that precede gene activation: (1) demethylation at CpG residues closely associated with CTCF occupancy across the ThymoD genomic region, (2) activation of cohesin-dependent looping to juxtapose the enhancer and promoter into a singleloop domain and to relocalize the enhancer from a heterochromatic to an euchromatic environment, and (3) deposition of activating epigenetic marks across the loop domain once positioned in the euchromatic compartment to facilitate interactions of paired regulatory elements by phase separation.
Mechanisms that Orchestrate Immune Cell Development
Previous studies have established that a subset of genomic regions reposition in the nucleus during the transition from the multipotent progenitor cell stage to committed B lineage cells Miyazaki et al., 2014; van Steensel and Belmont, 2017) . Switching the nuclear location of genomic regions is often associated with changes in gene expression Kind et al., 2015) . Prominent among the genomic regions that switch nuclear location in B cell progenitors are genes encoding for transcriptional regulators that specify B cell fate, including the EBF1 and FOXO1 loci Mansson et al., 2012) . Both loci are associated with the heterochromatic compartment in multipotent progenitors but reposition to the transcriptionally permissive compartment upon developing into committed B lineage cells . Here, we demonstrate that in developing T cell progenitors, a genomic region associated with the Bcl11b locus that harbors critical regulatory elements repositions from the nuclear lamina to the transcriptionally permissive nuclear interior. These findings point to a common mechanism that specifies B and T cell fate. In developing B cell progenitors, the EBF1 locus switches from the nuclear lamina to the transcriptionally permissive compartment, leading to the induction of EBF1 expression to establish B cell identity. In contrast, in T cell progenitors, the Bcl11b enhancer repositions from the lamina to the nuclear interior to activate Bcl11b expression. Why has such a complex mechanism, involving repression, nuclear repositioning, and activation, evolved to promote adaptive immune cell fate? We suggest that anchoring regulatory elements to the nuclear lamina permits efficient transcriptional repression across a large genomic region preventing stochastic and premature activation of a lymphoid-specific program of gene expression in hematopoietic progenitors. Only upon reaching a distinct developmental stage are progenitor cells instructed to release locus control regions or super enhancers from the nuclear lamina to the transcriptionally active compartment. In B cell progenitors, a repositioned EBF1 locus control region in the transcriptionally permissive compartment would associate with B-lineage-specific transcription factors such as E2A and FOXO1 to induce a B-lineage-specific program of gene expression . In T cell progenitors, the Bcl11b locus control region being positioned in the transcriptionally permissive compartment would be able to respond to Notch signaling and transcriptional regulators that include GATA3, TCF1, and RUNX1 to activate a T-lineage-specific transcription signature (Kueh et al., 2016) . Thus, specification of adaptive immune cell fate in early lymphoid progenitors is orchestrated by a common mechanism that involves the repositioning of regulatory regions from the lamina to the euchromatic compartment.
Non-coding Transcription and Tumor Suppression
The activation of anti-sense ThymoD transcription associated with a subset of lymphomas that were derived from ThymoD p(A)/p(A) mice was initially puzzling. How is anti-sense ThymoD transcription induced in a subset of lymphomas? Murine T cell lymphomas are frequently associated with mutations that activate the Notch signaling pathway, which activates Bcl11b expression (Weng et al., 2004; Yui and Rothenberg, 2014) . Although a detailed characterization of cooperating oncogenic mutations in the ThymoD p(A)/p(A) lymphomas will be required, we speculate that the aberrant activation of the Notch signaling cascade leads to the induction of high levels of anti-sense ThymoD transcription, ultimately leading to release of the Bcl11b intergenic region from the lamina. Since both sense and antisense ThymoD transcription are associated with changes in compartmentalization and chromatin folding, we suggest that ThymoD transcription, rather than its primary nucleotide sequence, is the critical determinant that dictates the specificity of Bcl11b enhancer-promoter communication.
Previous studies have demonstrated that somatic mutation of an intergenic region may generate an oncogenic superenhancer (Mansour et al., 2014) . Our observations indicate that non-coding transcription may act as a tumor suppressor. Given that non-coding transcription is widespread, we suggest that, likewise, non-coding transcription is a common mechanism to activate the expression of nearby genes that encode for proteins with tumor suppressive function.
Conclusion
It is now well established that the genomes of animal and plant kingdoms are organized into euchromatic and heterochromatic regions. Numerous studies have also identified genomic regions that switch nuclear location during developmental progression. The underlying mechanism that directs changes in compartmentalization, however, remained to be revealed. Here, we present data indicating that non-coding transcription dictates remodeling of local chromatin structure, possibly involving loop extrusion, to reposition regulatory elements from the heterochromatic to the euchromatic compartment. We suggest that local remodeling of chromatin topology by non-coding transcription-induced loop extrusion is a universal mechanism that permits genomic regions to readily switch compartments.
Enhancers are often separated from promoter regions by vast genomic distances. How enhancer elements select their cognate promoter regions with high precision and specificity remains to be revealed (Farley et al., 2015) . We suggest that developmental and lineage-specific patterns of non-coding transcription sequester, by loop extrusion, enhancer and promoter elements into a single-loop domain. Non-coding transcription-induced loop extrusion explains how enhancers and promoters, segregated from each other by vast genomic distances and positioned in separate compartments, find each other with great specificity during developmental progression.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Tsagaratou, A., Gonzá lez-Avalos, E., Rautio, S., Scott-Browne, J.P., Togher, S., Pastor, W.A., Rothenberg, E.V., Chavez, L., Lä hdesmä ki, H., and Rao, A. Mice ThymoD pA/pA mice were generated using CRISPR-Cas9 engineering in the embryonic core facility at the University of California, San Diego. All mice were bred in specific pathogen-free condition in accordance with the Institutional Animal Care and Use Committee of the University of California, San Diego.
T cell culture For OP9-DL1 culture, adult bone marrow single cell suspension were incubated with CD3e (145-2C11), B220 (RA3-6B2), CD11b (RB6-8C5), GR1 (RB6-8C5), TER119 (TER119), CD117 (2B8), CD127 (A7R37) and Flt3 (A2F10). Hematopoietic progenitor cells were collected by depleting lineage-positive cells using Automacs. Selected cells were cultured on OP9-DL1 in 6 well plates with aMEM containing 20% FCS, 2% PSG, FLT3L, recombinant IL-7 1-2 ng/ml at 37 C in 5% CO2.
ThymoD p(A)/p(A) tumor culture
Tumor 3 and tumor 6 were cultured on OP9-DLL1 in MEMa 20% FBS containing 5ng/ml Flt3-L, 5ng/ml IL7, 5ng/ml SCF, PSG at 37 C in 5% CO2. Tumor 5 was cultured without OP9-DLL1 in MEMa and 20% FBS containing 5ng/ml Flt3-L, 5ng/ml IL7, 5ng/ml SCF, PSG at 37 C in 5% CO2. All RNaseq data for tumors were obtained from primary cells. SMC3, RNA polII ChIP-seq was done for cultured tumors 3, 5 and primary tumor 6. DNA FISH was done for cultured tumor 3 and tmor 5.
METHOD DETAILS
Generating SCIDadh pA/pA cell line WT Cas9 was digested using NcoI/EcoRI from pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene) and cloned into pdCas9-humanized vector (Addgene) digested using NcoI/EcoRI. WT Cas9 and Pcl packaging vector were transfected into 293T cells using calcium phosphate precipitation. Virus supernatant was harvested at 48 hours. Spin infection was performed in 1x10 6 cells/ml concentration at 30 C for 90 min. Puromycin (final concentration 10ug/ml) was used for selection. sgRNA was generated by MEGAscript T7 transcription kit and MEGAclear transcription clean-up kit (ThermoFisher Scientific). In order to construct a repair template, gBlock gene fragments (Integrated DNA Technologies) carrying bGH poly(A) with 700bps homology arms that flank the gRNA target site were inserted in pGEM-T easy by NEBuilder HiFi DNA Assembly Master Mix (NEB). pAS knock in was conducted in a Neon transfection system (Invitrogen) using 10 mL tips. 1 3 10 6 of SCIDadh cells were harvested in a 1.5 mL tube and washed with PBS. Cells were suspended in 45 mL of buffer R. 3-4 mL of sgRNA ($20 ug) and 1-2 mL of repair template (10 mg/ml) were added in cell suspension to make a total 50 mL solution. 2 3 10 5 Cells were transfected at one time with run#3 (pulse voltage 1500, Pulse width 20, and Pulse no 1), then transferred to 1 well of 12 well plates with 1.5 mL of IMDM without PSG. The next day cells were transferred into Methocult M3630 (STEMCELL technology). Single colonies were picked and transferred into 96 well plates at day 3 and cultured for 5-6 days. Genotyping was performed for the cells isolated from each well.
sgRNA template sequence at upstream of ThymoD CR1 cagctGAATTCTAATACGACTCACTATAGGGGGAAAACACAGACCCTAGTCgttttagagctagaaatagcaagttaaaataaggctagtccGttatcAac ttgaaaaagtggcaccgagtcggtgc sgRNA template sequence at exon3 of thymoD (upstream of CR2) cagctGAATTCTAATACGACTCACTATAGGGTCTTCAAGGGTGCTATCACAgttttagagctagaaatagcaagttaaaataaggctagtccGttatcAactt gaaaaagtggcaccgagtcggtgc
Primers for genotyping at upstream of ThymoD CR1
IntCR1-2_F1 ATGGATGGAGAGGTGGACTG
IntCR1-2_R1 CCCTGAGAGAGCCCTAATCC int5_out CTCTGTCTGCCAACCCAACT
Primers for genotyping at exon3 (upstream of CR2)
Generating ThymoD pA/pA mice A sgRNA target site (TCTTCAAGGGTGCTATCACA) as described for SCIDadh pA/pA CR2 mutants was computationally identified in ThymoD exon 3 and verified by transfection of sgRNAs into a pro-B cell line (IM3) that stably expressed Streptococcus pyogenes WT Cas9 using the same method for generating SCIDadh mutant cell line. In order to construct a repair template, homology arms that flank the sgRNA target site were isolated from amplified C57BL/6 genomic DNA. Homology arms flanking a bGH poly(A) addition site were inserted in pGEM-T easy. The inserted poly(A) addition site is located upstream of CR2 region as well as 12kb upstream of the CR1 region (Li et al., 2013) . Next a mixture of sgRNA, Cas9 mRNA and repair template were injected in mouse zygotes using standard procedures. The inserted pAS sequence was detected by PCR. 
Primer for genotyping
Flow cytometry
For flow cytometry and cell sorting, single cell suspensions of thymus were prepared and analyzed as follows. Dead cells were eliminated using ghost dye red 780. Cells were stained with CD3e (145-2C11), CD4 (GK1.5; RM4-5), CD8a (53-6.7), CD11b (M1/70), CD19 (MB19-1), B220 (RA3-6B2), Gr1 (RB6-8C5), NK1.1(PK136), CD25 (PC61), CD27 (LG3A), CD44 (IM7), CD45.2 (104), CD117 (ack45), TCRb (H57-597), TCRgd (eBioGL3), Ter119 (TER119), and Thy1.2 (53-2.1) antibodies (Becton Dickinson and e-Biosciences). Antibodies were conjugated to fluorescein isothiocyanate, phycoerythrin, peridinin chlorophyll protein-cyanine 5.5, allophycocyanin, allophycocyanin-indotricarbocyanate, Pacific Blue, eFluor 450, Brilliant Violet 421 or were biotinylated. Biotynylated antibodies were stained using QD588 quantum dots (Life Technologies). Data were collected on a LSRII (BD Biosciences) and analyzed with FlowJo software (TreeStar). Cell sorting was performed on a FACSAriaII (BD).
Wright Giemsa staining
Cytospin was done at 1000rpm for 3min. Coverslips were stained by Wright solution for 3 min. Coverslips were washed into each well in 6well plate 2 times. Giemsa staining (1:10) was done for 7 min and washed into each well in 6well plate 2 times. Images were captured by an Olympus BH2 microscope.
Real-time PCR
For quantitative PCR cells were stored in buffer RLT (QIAGEN) with 2-Mercaptoethanol at À80 C. Total RNA was extracted using an RNeasy Mini Kit (QIAGEN) with DNase digestion (QIAGEN) or alternatively with RNeasy Micro Kit (QIAGEN) for small numbers of cells. cDNA was synthesized using a first-strand synthesis kit (Life Technologies) and oligo-dT primers. Conventional PCR was performed for cDNA with SYBR Green Master Mix (Roche). Previously reported primer sets were used for BCL11b and ARP detection (Ikawa et al., 2010) .
Primer for qPCR 3D-FISH For 3D-DNA FISH fosmid probes were used. WIBR1-1110C15 was used for the Bcl11b enhancer region and obtained from the BACPAC Resource Center (BPRC) at Children's Hospital Oakland Research Institute. Fosmid DNA was labeled with fluorochrome by Nick translation. 20ul solution consisted of 1mg of DNA, 4 ml of 5x Alexa fluor mix, 5x nick translatioin mix, 2 ml of 10x buffer was incubated at 15 C for 4 hour, heat killed by adding 1 ml of 0.5M EDTA pH 8 at 65 C for 10 min, and purified through ProbeQuant G-50 micro column. 2x10 5 cells/40 ml were put on the center of the poly-L-Lysine coated coverslip and cultured in 37 C for 30 min in cell culture incubator. Cells were washed with PBS, fixed at room temperature (RT) for 10 min with 4% paraformaldehyde in 1X PBS, pH 7.2. Fixed cells were quenched at RT for 10 min with 0.1 M Tris-Cl, pH 7.4, washed with PBS and stored in 1xPBS at 4 C for up to 1 month. Cells were permeabilized in 0.1% saponin, 0.1% Triton X-100, 1x PBS for 10 min at RT, incubated 20 min at RT with 20% glycerol, 1X PBS, freeze-thawed in liquid nitrogen three times and rinsed in 1x PBS. For immunofluorescence, cells were blocked at 37 C for 30 min in 5% BSA, 0.1% Triton X-100, 1X PBS and stained using a primary Lamin B1 (M-20) antibody (sc-6217) obtained from Santa Cruz Biotechnology at 1/150 dilution in the blocking buffer at 37 C for 30 min. Primary stained cell ThymoD F GGGCAGACGAAACTGACTGT were washed for 10 min at RT twice in 1X PBS, 0.1% Triton X-100 at RT with gentle agitation. For second staining, cells were blocked for 30 min at 37 C in 5% BSA, 0.1% Triton X-100, 5% donkey serum, 1X PBS, followed by secondary staining of donkey anti-goat IgG antibody conjugated to Alexa594 (A11058) (Invitrogen). Primary stained cell were washed for 10 min at RT twice in 1X PBS, 0.1% Triton X-100 at RT with gentle agitation, fixed again for 10 min at RT in 2% PFA, 1X PBS and quenched at RT for 10 min with 0.1 M Tris-Cl, pH 7.4, washed with PBS and stored in 1xPBS. For DNA-FISH, cells were denatured for 30 min in 0.1 M HCl at RT, blocked for 1hr at 37 C in 3% BSA + 100 mg/ml Rnase A in 1X PBS, and permeabilized for 30 min at RT in 0.5% saponin, 0.5% Triton X-100, 1X PBS. Cells were then washed once in PBS and stored in 2x SSC until hybridization. For hybridization, nuclear DNA was denatured by incubating coverslips for 2 min and 30 s at 73 C in 2x SSC, 70% formamide solution, followed by an incubation for 1 min in 2x SSC, 50% formamide solution. The hybridization solution contained 100 ng of labeled fosmid probe, 4 mg of mouse Cot-1 DNA, 1 mg of sheared salmon-sperm DNA dissoleved in 50% formamide, 4x SSC and 20% dextran sulfate. The probes were denatured at 73 C for 5 min. Denatured coverslips and probes were sealed and incubated at 37 C for over-night in hybridization oven. On the next day, coverslips were removed and washed once in 2x SSC, 50% formamide solution for 15 min and three times in 2x SSC for 5 min at 37 C with gentle agitation. Cells were washed once with PBS, excess PBS was removed and coverslips were mounted on slides with Prolong gold anti-fade reagent with DAPI (Invitrogen). Images were acquired on a Deltavision microscope using 100x objective lens. 0.2 mm optical sections were obtained in the DAPI, FITC and Red channels. The distances between the nuclear lamina and the BCL11b intergenic region were measured in 2D with ImageJ software.
In Situ Hi-C We used in situ Hi-C with minor modifications to generate a genome-wide contact map essentially consisted of 70 steps as described in the supplementary material (Rao et al., 2014) . Five million cells each of wild-type DN2 and ThymoDÀ/À DN2 cells were generated using OP9-DL1 stromal cells. For step 7, Complete Protease Inhibitor Cocktail, EDTA-free (Roche) was used. One tablet was dissolved in 1 mL dH 2 O. 5 ml of 50x Protease Inhibitor was used to 250 mL Hi-C lysis buffer. For step 8 and 9, centrifugation was done at 200x G for 5 min. For step 10, nuclei were resuspended in 0.5% SDS diluted in a final concentration of 1X NEB Buffer 2. For step 11, 5% Triton X-100 was used instead of 10%. For step 12, digestion efficiency was determined by using 3 ml of sample with 87 ml of 1x tris and 10 ml of proteinase-K. Samples were incubated at 55 C for 30 min, at 65 C with shaking for at least 1 hour, and purified with DNA clean & concentrator (Zymo Research). Samples were run on 0.6% agarose gel. For step 27, sheared DNA size should be 300-600 bps. Samples were checked by taking 1ml of sample and run on 2% agarose gel. For step 54-57 each sequencing library was incubated with USER enzyme for 15 min at 37 C after step 56. Final libraries were submitted to paired-end sequencing of 100 bp length on an Illumina HiSeq 2500.
ATAC-Seq ATAC-seq was performed as previously described (Buenrostro et al., 2013) . 50000 cells were used for library preparation. Washed cells were resuspended in lysis buffer. After washing, cells were treated with transposition mix for 30 min at 37 C. DNA was purified by DNA clean & concentrator (Zymo Research) . Library fragments were amplified using 1x NEBnext PCR master mix and 1.25 mM of custom Nextra PCR primers 1 and 2 with following PCR conditions: 72 C for 5 min, 98 C for 30 s, followed by thermocycling at 98 C for 10 s, 63 C for 30 s and 72 C for 1 min. Cycle of PCR amplification was determined by q-PCR with Sybr Green in order to stop amplification prior to saturation. Amplified 100-800 bps of Libraries were selected from 2% agarose gel. The quality of the library was checked with Agilent TapeStation and sequenced on an Illumina Hi-Seq4000.
ChIP-Seq
Chromatin was immunoprecipitated with following antibodies. CTCF antibody (07-729) was obtained from Millipore. H3.3 (ab176840), H3K4me1 (ab8895), H3K4me3 (ab8580), RNAPII 8WG16 (ab817) and SMC3 (ab9263) antibodies were purchased from Abcam. Cells were isolated from OP9-DL1 cultures and stained with FACS antibody and ghost dye to sort DN2 cells. Cells were fixed for 10 min in PBS containing 1% formaldehyde. Formaldehyde was quenched with 0.2 M glycine for 10 min. Lineage negative fixed DN2 cells were sorted by FACS AriaII and washed with PBS. Fixed cells were stored at À80 C until use. For preparation for cells treated with actinomycin D, lived cells were selected by ficol-paque plus (GE health care) at day 10. Selected live DN2 cells were suspended with MEM containing 20% FCS, 2% PSG, actinomycin D 10 ug/ml, IL7 and FLT3L and cultured without OP9-DLL1 for 1hr. Cells were harvested at 15, 30, and 60 min and immediately spun down and fixed as described above. Nuclei were isolated in cell buffer mix 10 mM of HEPES/KOH, 85 mM of KCL, 1 mM of EDTA, 1 mM of Benzamidine, 1x Protease inhibitor (Roche), 1% of NP-40 for 10-15 min on ice. Nuclei were spun down for 5 min at 3000 rpm and resuspended in lysis buffer with protease inhibitors. Nuclei were sonicated by Biorupter (Diagenode) with 20 cycles of 30 s on and 30 s off at high setting. Sonicated chromatin was immunnoprecipitated with antibodies coated on Protein G-Sepharose for over-night at 4 C. Samples were washed 5 times with LiCl wash buffer, mixing 3 min for each wash on a rotator and washed with TE buffer, mixing 1 min on rotator. Samples were resuspended in 200 mL IP Elution Buffer, incubated with 65 C thermomixer for 3 hr, mixed with 2 mL of protenase-K at 50 C for 1hr. Samples were placed on magnet and transferred to new 1.5ml Eppendorf tube and incubated at 65 C for over-night in hybridization oven for reverse cross-linking. DNA was purified by ChIP DNA clean & concentrator (Zymo Research) . Immunoprecipitated DNA was end-repaired, added with dATP by using Klenow exo-, ligated with adaptors from NEBNext Multiplex Oligos for Illumina (NEB) and purified with SPRI beads. Adaptor ligated DNA was amplified with NEBNext Multiplex Oligos for Illumina (NEB) and size-selected with SPRI beads. The quality of the library was checked with Agilent TapeStation. Libraries were run on Illumina Hi-Seq4000.
RNA-Seq
Total RNA was isolated from DN2 cells sorted by AriaII and treated with TURBO DNase (Ambion). mRNA was purified from total RNA by a Dynabeads mRNA purification kit (Life Technologies). cDNA was generated with a First-Strand Synthesis Kit (Life Technologies) and a random hexamers in presence of actinomycin D. Second-strand synthesis was performed with dUTP instead of dTTP. The double-stranded cDNA was sinicated to a length of 200-400 base pairs with S220 Focused-ultrasonicator (Covaris). Sonicated cDNA was ligated to adaptors. Libraries were prepared by TruSeq Stranded mRNA library prep kit (Illumina). Libraries for DN2 cells were sequenced for 50 cycles on Illumine HiSeq 2500.Total RNA from Tumor samples were isolated from whole enlarged thymus, prepared for library as same as DN2 RNA, and sequenced for 50 cycles on Illumina HiSeq 4000.
GRO-seq
Duplicates of GRO-seq experiments were performed. Nuclei from 5 million cells were isolated by hypotonic lysis. Nuclear run on (NRO) reaction was done for 5 min at 30 C in the presence of BrUTP 750 mM, ATP 750 mM, GTP 750 mM, reduced concentrations of CTP 4.5 mM and 1.65% sarkosyl. Total RNA was purified with Trizol and isopropanol precipitation, DNase treated (TURBO DNase, Ambion), fragmented with 2ul of fragmentation regent (Ambion AM1907). Fragmented RNA was re-buffered by P30 RNase-free spin column (Bio-Rad). RNA fragments were 3 0 dephosphorylated with T4 polynucleotide kinase. BrUTP-labeled run-on RNA was immunopurified with anti-BrdUTP-coated agarose beads, washed, and EtOH-precipitated. Run-on RNA was de-capped with tobacco acid pyrophosphatase from FirstChoice RLM-RACE kit (Thermo Fisher Scientific), 5 0 phosphorylated with polynucleotide kinase (NEB) and purified with Trizol LS/isopropanol precipitation.3 0 adaptor ligation was done by ligationg a single-stranded, 3 0 -blocked, 5 0 '-adenylated 3 0 oligonucleotide with mutant (K227Q) truncated RNA ligase 2 (NEB) to the 3 0 end of the RNA fragments, followed by annealing a reverse transcription primer complementary to the 3 0 adaptor to suppress adaptor dimer formation, and ligating a hybrid 5 0 DNA-RNA oligonucleotide using RNA ligase I and reverse-transcribing with SuperScript III reverse transcriptase (ThermoFisher Scientific). The cDNA was purified with SPRI beads. The libraries were amplified with primers bearing primer landing site compatible with illumine sequencing. The libraries were size-selected with 2% agarose containing SYBR gold to 60-110 bp insert size, followed by the quality of the library was checked with Agilent TapeStation and then sequenced for 50 cycles on Illumina HiSeq 2500.
Whole genome bisulfite sequencing (WGBS) Library preparation for WGBS was previously described (Benner et al., 2015) . DNA was isolated from in-vitro cultured WT DN2 and ThymoD pA/pA DN2 cells. 1 mg of genomic DNA mixed with unmethylated lamda DNA at a concentration of 0.5% of total DNA was sonicated by Biorupter with 20 cycles (30 s on and 30 s off at low condition). Fragmented DNA was end-repaired using the End-It procedure (Epicenter), and incubated in the presence of Klenow (3 0 to 5 0 exo minus) for adding an A base to the 3 0 end. Next TruSeq adapters were ligated to fragmented DNA and purified using 2% Agarose gel electrophoresis. Bisulfite conversion was performed as described by the manufacturer (MethylCode). Bisulfite-treated DNA was amplified by using a TruSeq PCR primer mixture and Pfu Turbo Cx Polymerase, agarose purified, and sequenced on an Illumina HiSEq 2500 sequencer.
QUANTIFICATION AND STATISTICAL ANALYSIS Filtering and Normalization of HiC Reads
Reads were first trimmed from the 3 0 end of sequences to GATC (MboI restriction enzyme site). Trimmed reads were aligned to mm9 with Bowtie software with parameters-chunkmbs 128-mm -m1-best-strata -p4 -S. The remainder of the analysis was performed using Homer (Heinz et al., 2010) . Only unique reads and paired end tags with more than 1.5x fragment length on the same chromosome separating them were retained. Sequence reads were checked for GC and nucleotide bias. HiC reads derived from wild-type DN2 and ThymoDpA/pA DN2 cells were compared to pro-B and multipotent progenitors . Tag counts for all directories were normalized to the sample with lowest sequencing depth. For multipotent progenitors, pro-B and wild-type DN2 comparisons a map resolution of 50 kb was chosen to ensure that > 80% of loci were associated with at least 1000 genomic contacts. A superRes of 100 kb was used for comparison of wild-type DN2 and ThymoDpA/pA DN2 cells. A resolution of 40 kb was chosen to ensure that greater than 80% of loci were associated with at least 1000 contacts. Hi-C heatmaps were normalized to output the ratio of observed to expected interactions by assuming each region has an equal chance of interacting with other regions in the genome and that regions are expected to interact depending on their linear distance along the chromosome . Hi-C heatmaps were visualized using Java Tree View. Circos diagrams were generated using Circos software. Only interactions with p values % 0.0001 are shown. Line thickness of Circos diagrams refers to p values. Darker lines depict lower p values. In depth explanations of normalization, generation of Hi-C correlation matrices, principal component analysis (PCA) and identifying significant interactions were performed as previously described .
Analysis for ATAC-Seq ATAC-Seq data were mapped to reference genome mm9 by Bowtie (version 1.1.1), using following option:-best -m 1, and others as default. The bam file were then processed by Homer to create tag directory with the default setting of Homer makeTagDirectory, using option -tbp 1. For ATAC open region, following options were used: localSize 50000 -size 150-minDist 50 -fragLength 0, and we used the default setting for other peak/region calling.
ChIP-Seq
ChIP-seq data were mapped to reference genome mm9 by Bowtie (version 1.1.1), using following option:-best -m 1, and others as default. The bam file were then processed by Homer to create tag directory with the default setting of Homer makeTagDirectory, using option -tbp 1. Homer findPeak has been used to identify enriched regions.
Analysis of CTCF direction and significant interaction p values associated with CTCF-CTCF interactions were computed as described by HOMER with the following modification. Bins were centered on CTCF bound site in wild-type or ThymoD p(A)/p(A) DN2 cells. CTCF directionality was identified by scanning using FIMO. The following parameter were used-motif CTCF_MOUSE.H10MO.A-text-thresh 0.01. MEME's mouse DNA-binding protein motif database was used (HOCOMOCOv10_MOUSE_mono_meme_format.meme). For multiple significant CTCF motifs that showed opposite directions within a CTCF binding site interactions originating from that site were identified as ''unknown.'' Analysis of SMC3 Occupancy in DN2 Cells Exposed to Actinomycin D DN2 cells were incubated in the presence of actinomycin D, formaldehyde fixed and analyzed for SMC3 occupancy using ChIP-seq as described above. Active transcription start sites were identified using RNA polymerase II ChIP-seq. Active TSS sites were defined by RNAPII peaks spanning a 2 kb window centered on the TSSs. -log 10 p values of the Fisher test were calculated for the contingency table. SMC reads were determined across the ThymoD locus (chr12: 108.345 À108.405 Mb) in DN2 cells treated in the absence or presence of actinomycin D and normalized to the total number of reads (10 7 read). The mean and standard deviation for each experiment were derived from 20 independent samples using boot strapping for all reads across the genome.
RNA-Seq
RNaseq data were examined using Omics Pipe applying the RNA-seq count-based differential expression analysis pipeline. Quality control of the raw fastq files was performed using FastQC (Babraham Bioinformatics). Sequencing reads were aligned to the mouse genome (mm10) applying STAR aligner. Read quantification (exons) was performed using htseq-count with UCSC RefSeq annotation. The R BioConductor package DESeq2 was used to calculate size factors in order to normalize library sizes across replicates and calculate means and variances based on a negative binomial distribution model in order to detect differentially expressed genes based on adjusted p values of < 0.05. Functional enrichment of the differentially expressed genes was done using ToppGene Suite, WebGestalt and Metascape.
Analysis of GRO-seq GRO-seq data were mapped to reference genome mm 9 by Bowtie (version 1.1.1), using following option:-best -m 1, and others as default. The bam file are then processed by Homer to create tag directory with the default setting of Homer makeTagDirectory, using option -tbp 1. UCSCfiles were generated with default setting with -strand separate.
Analysis of WGBS Analysis of bisulfite sequencing was performed using BSSeeker2 (Guo et al., 2013) , HOMER (Heinz et al., 2010) , and custom awk scripts. Specifically, a bisulfite-sequencing amenable mm9 reference genome was built using the BSSeeker2 script bs_seeker2-build.py with default options. Paired-end sequencing data were aligned to this reference genome using the BSSeeker2 script bs_seeker2-align.py allowing 6 mismatches (-m 6) and a fragment length between 0 and 800 bases (-I 0 -X 800). PCR duplicates were removed from paired end data using picard tools (https://broadinstitute.github.io/picard/). Unpaired reads were saved, aligned individually with the same options, and merged with paired-end data. Methylation levels were called using the BSSeeker2 script bs_seeker2-call_methylation.py with default settings. BSSeeker2 methylation call data were reformatted to the allC format (Lister et al., 2009 ) and tag directories were created using HOMER's makeTagDirectory command with the -minCounts 5 option, thus including only those cytosines covered by at least 5 reads. Downstream analysis comparing DNA methylation levels between wild-type and ThymoD pA/pA cells included only those cytosines covered by 5 reads in both datasets.
DATA AND SOFTWARE AVAILABILITY
Genome-wide reads were deposited at GEO. They are accessible for analysis at GEO: GSE90958 and at https://www.ncbi.nlm.nih. gov/geo/query/acc.cgi?token=avcrkuikxvsxxmr&acc=GSE90958. (Bossen et al., 2015) . Lower panel indicates ATAC-seq reads for DN2 cells. (B) Activation of ThymoD expression in the DN1 stage is initiated from the CR2 region (Zhang et al., 2012) . Tracks indicate RNA-seq data across the ThymoD region for DN1, DN2a, DN2b, DN3 and DP cells (Note: Derived from the Zhang et al., 2012 study). (C) Schematic diagram of the ThymoD genomic region. Upper panel shows the CR1, CR2, CR3, and CR4 regions as revealed using ATAC-seq. Middle panel indicates experimental strategy using CRISPR-Cas9 to insert p(A) cassette into a non-conserved genomic region of ThymoD. SCIDadh (DN2 like cells) were transfected with gRNAs and targeting template. Clones were isolated that harbor the poly(A) insertion as validated using PCR. Two independent clones that carry homozygous insertions for CR2 were isolated out of 100 clones. One independent clone was isolated from 600 carrying the poly(A) insertion upstream of CR1. 
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